Machine Learning to Predict Postoperative Pneumonia in Brain Tumor Patients
Key facts
- Who runs it
- Ming Yang
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 1,856 people enrolled
- Started
- 1 Aug 2024
- Ended
- 1 Sept 2025
- Type of study
- Observational, 5 groups
- Record updated
- 8 January 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Age ≥ 18 years
- Undergoing elective craniotomy for intracranial brain tumor resection
- Perioperative clinical data available in the electronic medical record to derive required predictors
- Expected postoperative survival ≥ 7 days
Who cannot take part
- Evidence of active infection (including pneumonia) prior to surgery
- Thoracic surgery or severe chest trauma within 30 days prior to craniotomy
- Spinal tumors or extracranial peripheral nerve tumors
- Pregnancy or lactation
- Hospice care, expected survival < 7 days, or insufficient data completeness for model calculation
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Postoperative pneumonia (POP) is a common and serious complication after elective craniotomy for brain tumor resection. POP often develops within the first week after surgery and may lead to prolonged hospitalization, higher medical costs, and increased risk of severe illness. Because symptoms can be subtle in neurosurgical patients, POP may be detected late, limiting timely prevention and treatment.
Read full original descriptionShow less
This study will evaluate whether a machine-learning-based clinical decision support tool can help clinicians identify patients at high risk for POP early and improve perioperative preventive care. The tool uses routinely collected clinical information to estimate an individual patient's POP risk and provides an easy-to-understand explanation of key risk drivers. Based on the predicted risk level (low, moderate, high, or very high), the system suggests standardized preventive care pathways (e.g., perioperative airway management, targeted antibiotic strategies per local practice, and nutritional support), while allowing clinicians to override recommendations at any time.
Participants will be adults undergoing their first elective craniotomy for brain tumor resection at participating neurosurgical centers. The primary outcome is the occurrence of POP within 7 days after surgery, defined using CDC/NHSN criteria. Secondary outcomes include antibiotic use intensity, length of hospital stay, direct medical cost, and clinician decision confidence. Participants will be followed at postoperative days 1, 3, and 7 using electronic medical record review and phone confirmation when needed.
The goal of this study is to determine whether integrating an explainable AI risk prediction tool into routine care can reduce POP and improve the quality and efficiency of perioperative management after brain tumor surgery.
The 5 groups in the trial
- Retrospective model development cohort (CAMS/PUMC, 2022-2024)
Retrospective cohort collected at the Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS/PUMC) between Jan 1, 2022 and Oct 31, 2024. Adult patients undergoing elective craniotomy for intracranial brain tumor resection were included. This cohort was used for model development, comparison of candidate algorithms, and internal validation; it was randomly split 8:2 into a training set (n=609) and an internal validation set (n=152). Early postoperative pneumonia (POP) was defined by CDC criteria within 7 days postoperatively. No study-mandated intervention was applied; routine perioperative care was provided.
- Prospective internal validation cohort (Test P, CAMS/PUMC)
Prospective cohort enrolled at CAMS/PUMC between Nov 1, 2024 and Apr 30, 2025 (Test P; n=224). Adult patients undergoing elective craniotomy for brain tumor resection were included. This cohort prospectively validated the finalized interpretable prediction model for early POP using routinely available perioperative EMR variables. Early POP was defined per CDC criteria within 7 postoperative days. Clinical management followed standard-of-care without any study-assigned intervention.
- Prospective external validation cohort (Test A, Anhui Medical Univ)
Prospective external validation cohort recruited at the First Affiliated Hospital of Anhui Medical University from Aug 1, 2024 to Apr 30, 2025 (Test A; n=329). Adult patients undergoing elective craniotomy for brain tumor resection were included. The cohort independently validated the finalized POP prediction model using routine perioperative data. Early POP was defined by CDC criteria within 7 days after surgery. No investigational intervention was administered; all care followed local standard practice.
- Prospective external validation cohort (Test S, Shandong Cancer Hospital)
Prospective external validation cohort recruited at Shandong Cancer Hospital from Aug 1, 2024 to Apr 30, 2025 (Test S; n=440). Adult patients undergoing elective craniotomy for intracranial brain tumor resection were included. This cohort was used to externally validate the finalized interpretable model for early POP prediction using routinely collected perioperative variables. Early POP was defined according to CDC criteria within 7 postoperative days. Participants received routine perioperative management per institutional standards without study-mandated interventions.
- Prospective external validation cohort (Test J, Jinan Fourth People's Hospital)
Prospective external validation cohort recruited at Jinan Fourth People's Hospital from Aug 1, 2024 to Apr 30, 2025 (Test J; n=102). Adult patients undergoing elective craniotomy for brain tumor resection were included. The cohort externally validated the finalized prediction model for early POP based on routine perioperative EMR data. Early POP was defined per CDC criteria within 7 postoperative days. There was no study-assigned intervention; all patients received standard perioperative care per local protocols.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- An Interpretable and Clinically Deployable Machine Learning Model for Predicting Early Postoperative Pneumonia of Brain Tumor: a Multicenter Diagnostic Study
- Record updated
- 8 January 2026